Page last updated: 2024-09-05

avasimibe and Hepatoblastoma

avasimibe has been researched along with Hepatoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, PH; Huff, MW; Newton, RS; Wilcox, LJ	1

Other Studies

1 other study(ies) available for avasimibe and Hepatoblastoma

Article	Year
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:4 Topics: Acetamides; Acetates; Apolipoprotein B-100; Apolipoproteins B; Carbon Radioisotopes; Coenzyme A; Enzyme Inhibitors; Hepatoblastoma; Humans; Hydroxymethylglutaryl CoA Reductases; Intracellular Fluid; Lipid Metabolism; Lipids; Receptors, LDL; RNA, Messenger; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured	1999

Article

Year

ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.

Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:4

Topics: Acetamides; Acetates; Apolipoprotein B-100; Apolipoproteins B; Carbon Radioisotopes; Coenzyme A; Enzyme Inhibitors; Hepatoblastoma; Humans; Hydroxymethylglutaryl CoA Reductases; Intracellular Fluid; Lipid Metabolism; Lipids; Receptors, LDL; RNA, Messenger; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured

1999